The genes we’re dealt
By Erik Parens,
Aeon
| 11. 10. 2020
Over the past decade, economists, sociologists and psychologists have begun collaborating with geneticists to investigate how genomic differences among human beings are linked to differences in their behaviours and social outcomes. The insights sought are wide-ranging: why do some of us have a greater sense of subjective wellbeing than others? Why do some go further in school than others? When it comes to income, why do some people earn more and others less?
As surprising as it might be to readers familiar with the history of often-ugly efforts to investigate complex behaviours and outcomes through genetics, some prominent members of this new cohort of researchers are optimistic that their work will advance progressive political agendas. According to the progressive authors of a recent European Commission report, insights from what I call ‘social genomics’ are ‘fully compatible with agendas that aim to combat inequalities and that embrace diversity.’
Indeed, findings from social genomics are compatible with what we in the United States consider Left-leaning agendas to combat inequalities. They are, however, equally compatible with what we think of as Right-leaning...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...